HIV-1 drug resistance mutations in children after failure of first-line nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy

HIV-1 drug resistance mutations in children after failure of first-line nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy

Objectives: The aim of the study was to assess the prevalence, predictors and patterns of genotypic resistance mutations in children after failure of World Health Organization-recommended initial nonnucleoside reverse transcriptase inhibitor (NNRTI)-based treatment regimens. Methods: We carried out...

Full description

Saved in:

Bibliographic Details
Main Authors:	Puthanakit T., Jourdain G., Hongsiriwon S., Suntarattiwong P., Chokephaibulkit K., Sirisanthana V., Kosalaraksa P., Petdachai W., Hansudewechakul R., Siangphoe U., Suwanlerk T., Ananworanich J.
Format:	Article
Language:	English
Published:	2014
Online Access:	http://www.scopus.com/inward/record.url?eid=2-s2.0-77955610006&partnerID=40&md5=90b9eac36c8b2d176fd130614920ee24 http://cmuir.cmu.ac.th/handle/6653943832/854
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	Chiang Mai University
Language:	English

Similar Items

HIV-1 drug resistance mutations in children after failure of first-line nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy
by: T. Puthanakit, et al.
Published: (2018)

HIV-1 drug resistance mutations in children after failure of first-line nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy
by: Puthanakit T., et al.
Published: (2014)

HIV-1 drug resistance mutations in children after failure of first-line nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy
by: T. Puthanakit, et al.
Published: (2018)

Low prevalence of insulin resistance among HIV-infected children receiving nonnucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy in Thailand
by: Lee B., et al.
Published: (2014)

Low prevalence of insulin resistance among HIV-infected children receiving nonnucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy in Thailand
by: B. Lee, et al.
Published: (2018)

Low prevalence of insulin resistance among HIV-infected children receiving nonnucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy in Thailand
by: B. Lee, et al.
Published: (2018)

Predictors of virologic failure and genotypic resistance mutation patterns in thai children receiving non-nucleoside reverse transcriptase inhibitor-based antiretroviral Therapy
by: Jittamala P., et al.
Published: (2014)

Reversal of growth failure in HIV-infected Thai children treated with non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy
by: Aurpibul L., et al.
Published: (2014)

Predictors of virologic failure and genotypic resistance mutation patterns in thai children receiving non-nucleoside reverse transcriptase inhibitor-based antiretroviral Therapy
by: Podjanee Jittamala, et al.
Published: (2018)

Predictors of virologic failure and genotypic resistance mutation patterns in thai children receiving non-nucleoside reverse transcriptase inhibitor-based antiretroviral Therapy
by: Podjanee Jittamala, et al.
Published: (2018)

Reversal of growth failure in HIV-infected Thai children treated with non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy
by: Linda Aurpibul, et al.
Published: (2018)

Reversal of growth failure in HIV-infected Thai children treated with non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy
by: Linda Aurpibul, et al.
Published: (2018)

Lipodystrophy and metabolic changes in HIV-infected children on non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy
by: Aurpibul L., et al.
Published: (2014)

Lipodystrophy and metabolic changes in HIV-infected children on non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy
by: Linda Aurpibul, et al.
Published: (2018)

Efficacy of non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy in thai hiv-infected children aged two years or less
by: Puthanakit T., et al.
Published: (2014)

Recovery From Lipodystrophy in HIV-infected Children After Substitution of Stavudine With Zidovudine in a Non-nucleoside Reverse Transcriptase Inhibitor-based Antiretroviral Therapy
by: Aurpibul L., et al.
Published: (2014)

Pattern and predictors of immunologic recovery in human immunodeficiency virus-infected children receiving non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy
by: Thanyawee Puthanakit, et al.
Published: (2018)

Pattern and predictors of immunologic recovery in human immunodeficiency virus-infected children receiving non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy
by: Thanyawee Puthanakit, et al.
Published: (2018)

Efficacy of non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy in thai hiv-infected children aged two years or less
by: Thanyawee Puthanakit, et al.
Published: (2018)

Efficacy of non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy in thai hiv-infected children aged two years or less
by: Thanyawee Puthanakit, et al.
Published: (2018)

Plasma drug concentrations and virologic evaluations after stopping treatment with nonnucleoside reverse-transcriptase inhibitors in HIV type 1-infected children
by: Cressey T.R., et al.
Published: (2014)

Plasma drug concentrations and virologic evaluations after stopping treatment with nonnucleoside reverse-transcriptase inhibitors in HIV type 1-infected children
by: Tim R. Cressey, et al.
Published: (2018)

Efficacy and tolerability of a double boosted protease inhibitor (lopinavir + saquinavir/ritonavir) regimen in HIV-infected patients who failed treatment with nonnucleoside reverse transcriptase inhibitors
by: P. Chetchotisakd, et al.
Published: (2018)

Efficacy and tolerability of a double boosted protease inhibitor (lopinavir + saquinavir/ritonavir) regimen in HIV-infected patients who failed treatment with nonnucleoside reverse transcriptase inhibitors
by: P. Chetchotisakd, et al.
Published: (2018)

Recovery from lipodystrophy in HIV-infected children after substitution of stavudine with zidovudine in a non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy
by: Linda Aurpibul, et al.
Published: (2018)

HIV-1 Drug resistance mutations in children who failed non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy
by: Somnuek Sungkanuparph, et al.
Published: (2018)

Multi-drug resistant HIV-1 reverse transcriptase genotype in children treated with dual nucleoside reverse transcriptase inhibitors (NRTIs)
by: Chulapan Engchanil, et al.
Published: (2018)

High rate multiple drug resistances in HIV-infected patients failing nonnucleoside reverse transcriptase inhibitor regimens in Thailand, where subtype A/E is predominant
by: Ploenchan Chetchotisakd, et al.
Published: (2018)

High rate multiple drug resistances in HIV-infected patients failing nonnucleoside reverse transcriptase inhibitor regimens in Thailand, where subtype A/E is predominant
by: Ploenchan Chetchotisakd, et al.
Published: (2018)

Non-Nucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy in Perinatally HIV-Infected, Treatment-Naïve Adolescents in Asia
by: Boettiger D., et al.
Published: (2017)

Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: Programmatic implications for countries phasing out stavudine
by: Tang M.W., et al.
Published: (2014)

Non-Nucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy in Perinatally HIV-Infected, Treatment-Naïve Adolescents in Asia
by: David C. Boettiger, et al.
Published: (2018)

Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: Programmatic implications for countries phasing out stavudine
by: Michele W. Tang, et al.
Published: (2018)

Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: Programmatic implications for countries phasing out stavudine
by: Michele W. Tang, et al.
Published: (2018)

HIV-1 reverse transcriptase inhibitors from family zingiberaceae
by: Kasem Sookkongwaree
Published: (2007)

A randomized trial comparing plasma drug concentrations and efficacies between 2 nonnucleoside reverse-transcriptase inhibitor-based regimens in hiv-infected patients receiving rifampicin: The n<inf>2</inf>r study
by: Weerawat Manosuthi, et al.
Published: (2018)

Second-line protease inhibitor-based HAART after failing non-nucleoside reverse transcriptase inhibitorbased regimens in Asian HIV-infected children
by: Torsak Bunupuradah, et al.
Published: (2018)

Second-line protease inhibitor-based HAART after failing non-nucleoside reverse transcriptase inhibitorbased regimens in Asian HIV-infected children
by: Torsak Bunupuradah, et al.
Published: (2018)

Second-line protease inhibitor-based HAART after failing non-nucleoside reverse transcriptase inhibitorbased regimens in Asian HIV-infected children
by: Torsak Bunupuradah, et al.
Published: (2018)

Docking study on phthalimide derivatives : HIV-1 reverse transcriptase inhibitors
by: Jiraporn Ungwitayatorn, et al.
Published: (2010)